172 related articles for article (PubMed ID: 26105818)
1. Antibody Structure.
Stanfield RL; Wilson IA
Microbiol Spectr; 2014 Apr; 2(2):. PubMed ID: 26105818
[TBL] [Abstract][Full Text] [Related]
2. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
[TBL] [Abstract][Full Text] [Related]
3. Structural and energetic hot-spots for the interaction between a ladder-like polycyclic ether and the anti-ciguatoxin antibody 10C9Fab.
Ui M; Tanaka Y; Tsumuraya T; Fujii I; Inoue M; Hirama M; Tsumoto K
Mol Biosyst; 2011 Mar; 7(3):793-8. PubMed ID: 21161086
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of human germline antibody 3-23/B3.
Malia TJ; Obmolova G; Almagro JC; Gilliland GL; Teplyakov A
Mol Immunol; 2011 Jul; 48(12-13):1586-8. PubMed ID: 21605907
[TBL] [Abstract][Full Text] [Related]
5. A universal combinatorial design of antibody framework to graft distinct CDR sequences: a bioinformatics approach.
Haidar JN; Yuan QA; Zeng L; Snavely M; Luna X; Zhang H; Zhu W; Ludwig DL; Zhu Z
Proteins; 2012 Mar; 80(3):896-912. PubMed ID: 22180101
[TBL] [Abstract][Full Text] [Related]
6. ABGEN: a knowledge-based automated approach for antibody structure modeling.
Mandal C; Kingery BD; Anchin JM; Subramaniam S; Linthicum DS
Nat Biotechnol; 1996 Mar; 14(3):323-8. PubMed ID: 9630894
[TBL] [Abstract][Full Text] [Related]
7. Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding.
Koenig P; Lee CV; Walters BT; Janakiraman V; Stinson J; Patapoff TW; Fuh G
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E486-E495. PubMed ID: 28057863
[TBL] [Abstract][Full Text] [Related]
8. Engineering antibodies for stability and efficient folding.
Honegger A
Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
[TBL] [Abstract][Full Text] [Related]
9. VL:VH domain rotations in engineered antibodies: crystal structures of the Fab fragments from two murine antitumor antibodies and their engineered human constructs.
Banfield MJ; King DJ; Mountain A; Brady RL
Proteins; 1997 Oct; 29(2):161-71. PubMed ID: 9329081
[TBL] [Abstract][Full Text] [Related]
10. Design and construction of synthetic phage-displayed Fab libraries.
Bostrom J; Fuh G
Methods Mol Biol; 2009; 562():17-35. PubMed ID: 19554284
[TBL] [Abstract][Full Text] [Related]
11. Properties of FV and Fab fragments of the antibody McPC603 expressed in E. coli.
Plückthun A; Glockshuber R; Skerra A; Stadmüller J
Behring Inst Mitt; 1990 Dec; (87):48-55. PubMed ID: 2096820
[TBL] [Abstract][Full Text] [Related]
12. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
[TBL] [Abstract][Full Text] [Related]
13. On the domain pairing in chimeric antibodies.
Teplyakov A; Obmolova G; Carton JM; Gao W; Zhao Y; Gilliland GL
Mol Immunol; 2010 Aug; 47(14):2422-6. PubMed ID: 20554002
[TBL] [Abstract][Full Text] [Related]
14. De novo selection of high-affinity antibodies from synthetic fab libraries displayed on phage as pIX fusion proteins.
Shi L; Wheeler JC; Sweet RW; Lu J; Luo J; Tornetta M; Whitaker B; Reddy R; Brittingham R; Borozdina L; Chen Q; Amegadzie B; Knight DM; Almagro JC; Tsui P
J Mol Biol; 2010 Mar; 397(2):385-96. PubMed ID: 20114051
[TBL] [Abstract][Full Text] [Related]
15. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
[TBL] [Abstract][Full Text] [Related]
16. The origin of enantioselectivity in aldolase antibodies: crystal structure, site-directed mutagenesis, and computational analysis.
Zhu X; Tanaka F; Hu Y; Heine A; Fuller R; Zhong G; Olson AJ; Lerner RA; Barbas CF; Wilson IA
J Mol Biol; 2004 Nov; 343(5):1269-80. PubMed ID: 15491612
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of synthetic antibodies binding to the cystic fibrosis conductance regulator.
Gakhal AK; Jensen TJ; Bozoky Z; Roldan A; Lukacs GL; Forman-Kay J; Riordan JR; Sidhu SS
MAbs; 2016; 8(6):1167-76. PubMed ID: 27185291
[TBL] [Abstract][Full Text] [Related]
18. Antibody evolution constrains conformational heterogeneity by tailoring protein dynamics.
Zimmermann J; Oakman EL; Thorpe IF; Shi X; Abbyad P; Brooks CL; Boxer SG; Romesberg FE
Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13722-7. PubMed ID: 16954202
[TBL] [Abstract][Full Text] [Related]
19. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
20. Specific recognition of a DNA immunogen by its elicited antibody.
Sanguineti S; Centeno Crowley JM; Lodeiro Merlo MF; Cerutti ML; Wilson IA; Goldbaum FA; Stanfield RL; de Prat-Gay G
J Mol Biol; 2007 Jun; 370(1):183-95. PubMed ID: 17512945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
